B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase

Journal of Experimental Medicine

Volumn 206, Issue 1, 2009, Pages 125-138

  Cariappa, Annaiah ^a   Takematsu, Hiromu ^b,d   Liu, Haoyuan ^a   Diaz, Sandra ^b   Haider, Khaleda ^a   Boboila, Cristian ^a   Kalloo, Geetika ^a   Connole, Michelle ^c   Shi, Hai Ning ^a   Varki, Nissi ^b   Varki, Ajit ^b   Pillai, Shiv ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b University of California San Diego   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

9 O ACETYL SIALIC ACID ESTERASE; AUTOANTIBODY; B LYMPHOCYTE ANTIGEN; B LYMPHOCYTE ANTIGEN RECEPTOR; BINDING PROTEIN; CARBOHYDRATE; CD22 ANTIGEN; SIALIC ACID DERIVATIVE; UNCLASSIFIED DRUG; ANTINUCLEAR ANTIBODY; CARBOXYLESTERASE; CD22 PROTEIN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN TYROSINE PHOSPHATASE SHP 1; PTPN6 PROTEIN, MOUSE; SIALATE O ACETYLESTERASE; SIALATE O-ACETYLESTERASE;

ACETYLATION; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELL SURFACE; DEACETYLATION; ENZYME ACTIVATION; ENZYME REGULATION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; THYMUS; ANIMAL; BIOLOGICAL MODEL; BLOOD; BONE MARROW CELL; C57BL MOUSE; CELL COUNT; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; GLOMERULONEPHRITIS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; MOUSE STRAIN; MUTATION; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN; WESTERN BLOTTING;

ACETYLATION; ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD22; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; BLOTTING, WESTERN; BONE MARROW CELLS; CARBOXYLIC ESTER HYDROLASES; CELL COUNT; CELL DIFFERENTIATION; GLOMERULONEPHRITIS; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MUTATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RECEPTORS, ANTIGEN, B-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIALIC ACIDS; SIGNAL TRANSDUCTION; SPLEEN;

EID: 60549105605     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20081399     Document Type: Article

References (61)

1. Schauer, R. 2000. Achievements and challenges of sialic acid research. Glycoconj.J. 17:485-499.
2. Angata, T., and A. Varki. 2002. Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chem. Rev. 102:439-469.
3. Herrler, G., R. Rott, H.D. Klenk, H.P. Muller, A.K. Shukla, and R. Schauer. 1985. The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO J. 4:1503-1506.
4. Vlasak, R., W. Luytjes, W. Spaan, and P. Palese. 1988. Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses. Proc. Natl. Acad. Sci. USA. 85:4526-4529.
5. Varki, A., F. Hooshmand, S. Diaz, N.M. Varki, and S.M. Hedrick. 1991. Developmental abnormalities in transgenic mice expressing a sialic acid-specific 9-O-acetylesterase. Cell. 65:65-74.
6. Sjoberg, E.R., L.D. Powell, A. Klein, and A. Varki. 1994. Natural li-gands of the B cell adhesion molecule CD22β can be masked by 9-O- acetylation of sialic acids. J. Cell Biol. 126:549-562.
7. Varki, A. 2007. Glycan-based interactions involving vertebrate sialic- acid-recognizing proteins. Nature. 446:1023-1029.
8. Crocker, P.R., J.C. Paulson, and A. Varki. 2007. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7:255-266.
9. Crocker, P.R. 2002. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. Curr. Opin. Struct. Biol. 12:609-615.
10. Powell, L.D., D. Sgroi, E.R. Sjoberg, I. Stamenkovic, and A. Varki. 1993. Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked oligosaccharides with alpha-2,6-linked sialic acids that are required for recognition. J. Biol. Chem. 268:7019-7027.
11. Jin, L., P.A. McLean, B.G. Neel, and H.H. Wortis. 2002. Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling. J. Exp. Med. 195:1199-1205.
12. Doody, G.M., L.B. J ustement, C.C. Delibrias, R.J. Matthews, J. Lin, M.L. Thomas, and D.T. Fearon. 1995. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science. 269:242-244.
13. O'Keefe, T.L., G.T. Williams, S.L. Davies, and M.S. Neuberger. 1996. Hyperresponsive B cells in CD22-deficient mice. Science. 274:798-801.
14. Otipoby, K.L., K.B. Andersson, K.E. Draves, S.J. Klaus, A.G. Farr, J.D. Kerner, R.M. Perlmutter, C.L. Law, and E.A. Clark. 1996. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature. 384:634-637.
15. Sato, S., A.S. Miller, M. Inaoki, C.B. Bock, P.J. Jansen, M.L. Tang, and T.F. Tedder. 1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity. 5:551-562.
16. Nitschke, L., R. Carsetti, B. Ocker, G. Kohler, and M.C. Lamers. 1997. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 7:133-143.
17. Hibbs, M.L., D.M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S.A. Stacker, and A.R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell. 83:301-311.
18. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. I lic, S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity. 3:549-560.
19. Chan, V.W., F. Meng, P. Soriano, A.L. DeFranco, and C.A. Lowell. 1997. Characterization of the B lymphocyte populations in Lyn-defi-cient mice and the role of Lyn in signal initiation and down-regulation. Immunity. 7:69-81.
20. Cyster, J.G., and C.C. Goodnow. 1995. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity. 2:13-24.
21. Pao, L.I., K.P. Lam, J.M. Henderson, J.L. Kutok, M. Alimzhanov, L. Nitschke, M.L. Thomas, B.G. Neel, and K. Rajewsky. 2007. B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity. 27:35-48.
22. Poe, J.C., Y. Fujimoto, M. Hasegawa, K.M. Haas, A.S. Miller, I.G. Sanford, C.B. Bock, M. Fujimoto, and T.F. Tedder. 2004. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat. Immunol. 5:1078-1087.
23. Collins, B.E., B.A. Smith, P. Bengtson, and J.C. Paulson. 2006. Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling. Nat. Immunol. 7:199-206.
24. Walker, J.A., and K.G. Smith. 2008. CD22: an inhibitory enigma. Immunology. 123:314-325.
25. Guimaraes, M.J., J.F. Bazan, J. Castagnola, S. Diaz, N.G. Copeland, D.J. Gilbert, N.A. Jenkins, A. Varki, and A. Zlotnik. 1996. Molecular cloning and characterization of lysosomal sialic acid O-acetylesterase. J. Biol. Chem. 271:13697-13705.
26. Stoddart, A., Y. Zhang, and C.J. Paige. 1996. Molecular cloning of the cDNA encoding a murine sialic acid-specific 9-O-acetylesterase and RNA expression in cells of hematopoietic and non-hematopoietic origin. Nucleic Acids Res. 24:4003-4008.
27. Takematsu, H., S. Diaz, A. Stoddart, Y. Zhang, and A. Varki. 1999. Lysosomal and cytosolic sialic acid 9-O-acetylesterase activities can be encoded by one gene via differential usage of a signal peptide-encoding exon at the N terminus. J. Biol. Chem. 274:25623-25631.
28. Krishna, M., and A. Varki. 1997. 9-O-Acetylation of sialomucins: a novel marker of murine CD4 T cells that is regulated during maturation and activation. J. Exp. Med. 185:1997-2013.
29. Cariappa, A., M. Tang, C. Parng, E. Nebelitskiy, M. Carroll, K. Georgopoulos, and S. Pillai. 2001. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity. 14:603-615.
30. Samardzic, T., D. Marinkovic, C.P. Danzer, J. Gerlach, L. Nitschke, and T. Wirth. 2002. Reduction of marginal zone B cells in CD22-defi- cient mice. Eur. J. Immunol. 32:561-567.
31. Pillai, S., A. Cariappa, and S.T. Moran. 2005. Marginal Zone B Cells. Annu. Rev. Immunol. 23:161-196.
32. Cariappa, A., I.B. Mazo, C. Chase, H.N. Shi, H. Liu, Q. Li, H. Rose, H. Leung, B.J. Cherayil, P. Russell, et al. 2005. Perisinusoidal B cells in the bone marrow participate in T-independent responses to blood-borne microbes. Immunity. 23:397-407.
33. Cariappa, A., C. Chase, H. Liu, P. Russell, and S. Pillai. 2007. Naive recirculating B cells mature simultaneously in the spleen and bone marrow. Blood. 109:2339-2345.
34. Wang, J.H., N. Avitahl, A. Cariappa, C. Friedrich, T. Ikeda, A. Renold, K. Andrikopoulos, L. Liang, S. Pillai, B.A. Morgan, and K. Georgopoulos. 1998. Aiolos regulates B cell activation and maturation to effector state. Immunity. 9:543-554.
35. Pan, C., N. Baumgarth, and J.R. Parnes. 1999. CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation. Immunity. 11:495-506.
36. Ngo, V.N., R.J. Cornall, and J.G. Cyster. 2001. Splenic T zone development is B cell dependent. J. Exp. Med. 194:1649-1660.
37. Hennet, T., D. Chui, J.C. Paulson, and J.D. Marth. 1998. I mmune regulation by the ST6Gal sialyltransferase. Proc. Natl. Acad. Sci. USA. 95:4504-4509.
38. Marino, J.H., C. Tan, B. Davis, E.S. Han, M. Hickey, R. Naukam, A. Taylor, K.S. Miller, C.J. Van De Wiele, and T.K. Teague. 2008. Disruption of thymopoiesis in ST6Gal I-deficient mice. Glycobiology. 18:719-726.
39. Blixt, O., B.E. Collins, I.M. van den Nieuwenhof, P.R. Crocker, and J.C. Paulson. 2003. Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of my-elin-associated glycoprotein. J. Biol. Chem. 278:31007-31019.
40. Brinkman-Van der Linden, E.C., E.R. Sjoberg, L.R. Juneja, P.R. Crocker, N. Varki, and A. Varki. 2000. Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs. J. Biol. Chem. 275:8633-8640.
41. Kelm, S., R. Brossmer, R. I secke, H.J. Gross, K. Strenge, and R. Schauer. 1998. Functional groups of sialic acids involved in binding to siglecs (sialoadhesins) deduced from interactions with synthetic analogues. Eur. J. Biochem. 255:663-672.
42. Collins, B.E., O. Blixt, N.V. Bovin, C.P. Danzer, D. Chui, J.D. Marth, L. Nitschke, and J.C. Paulson. 2002. Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22. Glycobiology. 12:563-571.
43. Hedlund, M., P. Tangvoranuntakul, H. Takematsu, J.M. Long, G.D. Housley, Y. Kozutsumi, A. Suzuki, A. Wynshaw-Boris, A.F. Ryan, R.L. Gallo, et al. 2007. N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution. Mol. Cell. Biol. 27:4340-4346.
44. Naito, Y., H. Takematsu, S. Koyama, S. Miyake, H. Yamamoto, R. Fujinawa, M. Sugai, Y. Okuno, G. Tsujimoto, T. Yamaji, et al. 2007. Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation. Mol. Cell. Biol. 27:3008-3022.
45. O'Keefe, T.L., G.T. Williams, F.D. Batista, and M.S. Neuberger. 1999. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 189:1307-1313.
46. Cornall, R.J., J.G. Cyster, M.L. Hibbs, A.R. Dunn, K.L. Otipoby, E.A. Clark, and C.C. Goodnow. 1998. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity. 8:497-508.
47. Tedder, T.F., M. Inaoki, and S. Sato. 1997. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity. 6:107-118.
48. Kelm, S., J. Gerlach, R. Brossmer, C.P. Danzer, and L. Nitschke. 2002. The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound. J. Exp. Med. 195:1207-1213.
49. Watkins-Chow, D.E., and W.J. Pavan. 2008. Genomic copy number and expression variation within the C57BL/6J inbred mouse strain. Genome Res. 18:60-66.
50. Han, S., B.E. Collins, P. Bengtson, and J.C. Paulson. 2005. Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking. Nat. Chem. Biol. 1:93-97.
51. Ghosh, S., C. Bandulet, and L. Nitschke. 2006. Regulation of B cell development and B cell signalling by CD22 and its ligands alpha2,6-linked sialic acids. Int. Immunol. 18:603-611.
52. Martin, L.T., J.D. Marth, A. Varki, and N.M. Varki. 2002. Genetically altered mice with different sialyltransferase deficiencies show tissue- specific alterations in sialylation and sialic acid 9-O-acetylation. J. Biol. Chem. 277:32930-32938.
53. Hoffmann, A., S. Kerr, J. Jellusova, J. Zhang, F. Weisel, U. Wellmann, T.H. Winkler, B. Kneitz, P.R. Crocker, and L. Nitschke. 2007. Siglec- G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population. Nat. Immunol. 8:695-704.
54. Ferry, H., T.L. Crockford, K. Silver, N. Rust, C.C. Goodnow, and R.J. Cornall. 2005. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival. Eur. J. Immunol. 35:3655-3663.
55. Shi, W.X., R. Chammas, and A. Varki. 1998. Induction of sialic acid 9-O-acetylation by diverse gene products: implications for the expression cloning of sialic acid O-acetyltransferases. Glycobiology. 8:199-205.
56. Chui, D., M. Oh-Eda, Y.F. Liao, K. Panneerselvam, A. Lal, K.W. Marek, H.H. Freeze, K.W. Moremen, M.N. Fukuda, and J.D. Marth. 1997. Alpha-mannosidase-II deficiency results in dyserythropoiesis and unveils an alternate pathway in oligosaccharide biosynthesis. Cell. 90:157-167.
57. Cariappa, A., T.J. Kim, and S. Pillai. 1999. Accelerated emigration of B lymphocytes in the Xid mouse. J. Immunol. 162:4417-4423.
58. Martin, L.T., A. Verhagen, and A. Varki. 2003. Recombinant influenza C hemagglutinin-esterase as a probe for sialic acid 9-O-acetylation. Methods Enzymol. 363:489-498.
59. Cariappa, A., H.C. Liou, B.H. Horwitz, and S. Pillai. 2000. Nuclear factor κB is required for the development of marginal zone B lymphocytes. J. Exp. Med. 192:1175-1182.
60. Cariappa, A., T. Shoham, H. Liu, S. Levy, C. Boucheix, and S. Pillai. 2005. The CD9 tetraspanin is not required for the development of peripheral B cells or for humoral immunity. J. Immunol. 175:2925-2930.
61. Cariappa, A., C. Boboila, S.T. Moran, H. Liu, H.N. Shi, and S. Pillai. 2007. The recirculating B cell pool contains two functionally distinct, long-lived, posttransitional, follicular B cell populations. J. Immunol. 179:2270-2281.